MHSEcho-img-2022-IN-01-0900-Julio Sánchez y Tépoz
News Article
As Mexico’s population ages, the pharmaceutical sector will direct its attention to chronic non-communicable diseases.
Sandra Sánchez-Oldenhage
Expert Contributor
Sandra Sánchez-Oldenhage
PharmaAdvice Consulting
It is becoming clear that the post-COVID-19 recovery will be a time of real change and, potentially, challenging for pharma companies
View from the Top
Philippe Fournet-Fayard
CEO and General Manager
Eolis América Latina
Eolis is founder of the Mexican Chapter of ISPE, creating a strong knowledge on sharing a structure that will enhance engineering quality in Mexico
Subscribe to pharmaceutical sector